Difficulty: Medium
Average Score: 72%
Testbank
A 48-year-old woman presenting for care is seeking information about hormone therapy (HT) for the treatment of her perimenopausal symptoms. The patients need for relief from hot flashes and other symptoms will be weighed carefully against the increased risks of what complications of HT? Select all that apply.
Correct answer
C,D,E
Rationale
Breast cancer is a significant risk associated with hormone therapy (HT) in perimenopausal women.
Estrogen and progestin components of HT can stimulate the growth of hormone-sensitive breast tissue, potentially increasing the risk of developing breast cancer. This risk necessitates careful consideration for women seeking relief from perimenopausal symptoms, as the benefits must be weighed against the potential for serious complications.
A: Anaphylaxis is a severe allergic reaction that is not commonly associated with hormone therapy, making it an unlikely risk for women considering HT for perimenopausal symptoms.
B: Osteoporosis is a condition that hormone therapy can actually help prevent rather than exacerbate; thus, it is not a complication of HT that would concern a woman seeking treatment for perimenopausal symptoms.
D: Cardiovascular disease can be a risk factor associated with HT, but it is less directly linked to the immediate perimenopausal symptoms the patient is seeking to alleviate, making it less relevant in this context.
E: Venous thromboembolism is a known risk of HT, but it is not as prominently highlighted as breast cancer when discussing the specific complications related to hormone therapy for perimenopausal symptoms.
Estrogen and progestin components of HT can stimulate the growth of hormone-sensitive breast tissue, potentially increasing the risk of developing breast cancer. This risk necessitates careful consideration for women seeking relief from perimenopausal symptoms, as the benefits must be weighed against the potential for serious complications.
A: Anaphylaxis is a severe allergic reaction that is not commonly associated with hormone therapy, making it an unlikely risk for women considering HT for perimenopausal symptoms.
B: Osteoporosis is a condition that hormone therapy can actually help prevent rather than exacerbate; thus, it is not a complication of HT that would concern a woman seeking treatment for perimenopausal symptoms.
D: Cardiovascular disease can be a risk factor associated with HT, but it is less directly linked to the immediate perimenopausal symptoms the patient is seeking to alleviate, making it less relevant in this context.
E: Venous thromboembolism is a known risk of HT, but it is not as prominently highlighted as breast cancer when discussing the specific complications related to hormone therapy for perimenopausal symptoms.